tradingkey.logo
tradingkey.logo
Search

Sonoma Pharmaceuticals Inc

SNOA
Add to Watchlist
1.100USD
-0.030-2.65%
Close 07-31 16:00ETQuotes delayed by 15 min
1.98MMarket Cap
LossP/E TTM

Sonoma Pharmaceuticals Inc

1.100
-0.030-2.65%
View Detailed Chart
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-2.65%

5 Days

-3.51%

1 Month

-9.09%

6 Months

-66.46%

Year to Date

-69.78%

1 Year

-63.09%

Key Figures
1.120Open
1.140High
28.58KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
1.59%Turnover Ratio
1.130Prev. Close
1.100Low
29.39KTurnover
LossP/E Static
0.64P/B
0.00%Div Yield TTM
-24.70%ROA
6.92052wk High
0.80Volume Ratio
-3.46MNet Profit
1.80MShares
-1.9416EPS TTM
1.29Beta
-81.19%ROE
0.85052wk Low
3.54%Amplitude
39.22%Gross Margin
1.98MMarket Cap
-1.61Reward/Risk
4.12%Risk Rate

Key Insights

Sonoma Pharmaceuticals Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 114 out of 155 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as , with the highest price target at 14.80.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Sonoma Pharmaceuticals Inc's Score

Industry at a Glance

Industry Ranking
114 / 155
Overall Ranking
325 / 4281
Industry
Pharmaceuticals

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Sonoma Pharmaceuticals Inc Highlights

StrengthsRisks
Sonoma Pharmaceuticals, Inc. is a global healthcare company. The Company is engaged in developing and producing stabilized hypochlorous acid (HOCl) products for a range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. Its products are all classified as medical devices and categorized as prescription, over-the-counter (OTC) and office dispense products. It offers both prescription and OTC dermatology products, including Epicyn Facial Cleanser, Levicyn Dermal Spray, Levicyn Gel, Levicyn Spray Gel, Celacyn Scar Management Gel. In the United States, it offers Microcyn wound and skin care both as an OTC and prescription product. Its eyecare products include Acuiycn Eyelid and Eyelash Hygiene, and Ocucyn Eyelid and Eyelash Cleanser. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a wide spectrum of animal wounds and infections.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 53.35% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 19.53M.
Fairly Valued
The company’s latest PE is -0.57, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 127.80K shares, decreasing 21.35% quarter-over-quarter.

Analyst Rating

Based on 0 analysts
--
Current Rating
14.800
Target Price
+1198.25%
Upside Space

Sonoma Pharmaceuticals Inc News

More news coming soon, stay tuned...

Earnings Forecast

Analyst Rating

Based on 0 analysts
--
Current Rating
14.800
Target Price
+1198.25%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

160
Total
6
Median
9
Average
Company name
Ratings
Analysts
Sonoma Pharmaceuticals Inc
SNOA
0
Biogen Inc
BIIB
38
Amgen Inc
AMGN
38
Eli Lilly and Co
LLY
34
AbbVie Inc
ABBV
33
Pfizer Inc
PFE
32
1
2
3
...
32

Indicators

Indicators
Sell(4)
Neutral(1)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.022
Sell
RSI(14)
37.414
Neutral
STOCH(KDJ)(9,3,3)
8.914
Oversold
ATR(14)
0.053
High Vlolatility
CCI(14)
-120.867
Sell
Williams %R
100.000
Oversold
TRIX(12,20)
-0.168
Sell
StochRSI(14)
34.881
Sell
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
1.124
Sell
MA10
1.144
Sell
MA20
1.191
Sell
MA50
1.159
Sell
MA100
1.524
Sell
MA200
2.461
Sell

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Sonoma Pharmaceuticals Inc Info

Sonoma Pharmaceuticals, Inc. is a global healthcare company. The Company is engaged in developing and producing stabilized hypochlorous acid (HOCl) products for a range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. Its products are all classified as medical devices and categorized as prescription, over-the-counter (OTC) and office dispense products. It offers both prescription and OTC dermatology products, including Epicyn Facial Cleanser, Levicyn Dermal Spray, Levicyn Gel, Levicyn Spray Gel, Celacyn Scar Management Gel. In the United States, it offers Microcyn wound and skin care both as an OTC and prescription product. Its eyecare products include Acuiycn Eyelid and Eyelash Hygiene, and Ocucyn Eyelid and Eyelash Cleanser. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a wide spectrum of animal wounds and infections.
Ticker SymbolSNOA
CompanySonoma Pharmaceuticals Inc
CEOTrombly (Amy)
Websitehttps://sonomapharma.com/

Shareholders

Shareholders
Shareholders
Proportion
DRW Securities, LLC
1.76%
Vanguard Capital Management, LLC
0.54%
Geode Capital Management, L.L.C.
0.46%
McKinley Carter Wealth Services, Inc.
0.32%
Thornton (Bruce)
0.22%
Other
96.70%

FAQs

What is the current price of Sonoma Pharmaceuticals Inc (SNOA)?

The current price of Sonoma Pharmaceuticals Inc (SNOA) is 1.10.

What is the symbol of Sonoma Pharmaceuticals Inc?

The ticker symbol of Sonoma Pharmaceuticals Inc is SNOA.

What is the 52-week high of Sonoma Pharmaceuticals Inc?

The 52-week high of Sonoma Pharmaceuticals Inc is 6.92.

What is the 52-week low of Sonoma Pharmaceuticals Inc?

The 52-week low of Sonoma Pharmaceuticals Inc is 0.85.

What is the market capitalization of Sonoma Pharmaceuticals Inc?

The market capitalization of Sonoma Pharmaceuticals Inc is 1.98M.

What is the Earnings Per Share (EPS TTM) of Sonoma Pharmaceuticals Inc (SNOA)?

The Earnings Per Share (EPS TTM) of Sonoma Pharmaceuticals Inc (SNOA) is -1.89.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.